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Abstract 
The gut microbiota, a complex and dynamic community of microbes in the mammalian gut, has 
coevolved with us for ample time providing mutual benefits. However, mechanistic knowledge 
of these has been limited, but are now becoming increasingly clear. We used germ-free mice to 
study three aspects of host physiology; the effects of the microbiota on small intestinal postnatal 
vascularization (I), small intestinal permeability (II), as well as the interplay between the gut 
microbiota and a steatogenic diet and the subsequent effects on hepatic metabolism (III). 
In Paper I we found a new mechanism underlying microbiota-induced vascular remodeling in 
small intestinal villi. This mechanism involves activation of protease activated receptor-1 
(PAR1) induced by microbial regulation of tissue factor activity. As a consequence of PAR1 
signaling we observe increased angiopoietin expression in the intestinal epithelium and 
subsequent expansion of blood vasculature.  
In Paper II we applied Ussing chambers technique to measure small intestinal permeability and 
observed increased permeability in conventionally raised (CONV-R) mice, compared with 
germ-free (GF) mice. This was accompanied by reduced mRNA expression of tight junction 
proteins and ultrastructure analyses revealed wider tight junctions and reduced numbers of 
desmosomes. The alterations between GF and CONV-R mice were abolished in the absence of 
farnesoid X receptor.  
In Paper III we investigated if the gut microbiota interacted with dietary sucrose to induce 
hepatic steatosis. GF and CONV-R mice were fed a zero-fat, high-sucrose diet (ZFD) or control 
diet and we observed a synergistic effect of diet and microbiota on hepatic steatosis by 
induction of de novo lipogenesis. Furthermore, we could establish a central role for the 
transcription factor sterol regulatory element-binding protein-1c (SREBP-1c) in this process.  
  
In conclusion, these studies show that the microbiota induces expansion of intestinal vasculature 
and increased permeability, which may both contribute to metabolic effects. Further, the 
microbiota is required for a zero-fat, high sucrose diet to be steatogenic. This could give rise to 
novel treatment options for non-alcoholic fatty liver disease. 
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